Global Small-scale Bioreactors Market Size, Trends & Growth Opportunity, By Product (Reusable Bioreactors , Single-use Bioreactors), By Capacity (5 ML -100 ML, 100 ML-250 ML, 250 ML -500 ML, 500 ML-1 L, 1L-3L, 3L-5L), By End-use (Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes) By Region and Forecast till 2030.
Global Small-scale Bioreactors Market
The global Small-scale Bioreactors market was valued at USD 1.8 billion in 2022 which expected to reach USD 5.05 billion by 2030 at a CAGR 12.27 % from 2023-2030.
The purpose of bioreactors is to provide an efficient environment for cells or enzymes during biochemical processes involving biologically active chemicals and microorganisms. Anaerobic or aerobic reactions take place in the bioreactor. There are several different kinds of bioreactors, including glass bioreactors, carbon steel bioreactors, stainless steel bioreactors, ceramic bioreactors, and PTFE plastic bioreactors, which are all cylindrical structures with a range of capacities.
Market Drivers
The development of novel biological therapeutics is receiving increased attention as a result of the rising prevalence of chronic diseases like cancer, heart disease, diabetes, and hypertension. Similar to this, the demand for monoclonal antibodies and customised medications has boosted bioproduction, driving up the need for small-scale bioreactors. Also, during the projection period, there will be a rise in the use of sophisticated technologies to streamline complex production, which will increase demand for small-scale bioreactors.
Market Opportunity
The company will have the chance to develop and market its line of single-use bioreactor devices and outsourced process design services. The biopharmaceutical industry is rapidly transitioning to the use of single-use bioprocessing systems with integrated real-time monitoring and technical analysis that can facilitate automation, enhance data-driven quality control, and continue driving performance due to the demand for better quality and greater efficiency in drug manufacturing.
Impact of COVID-19
These bioprocessing devices, which come in sizes ranging from a few millilitres to 5-10 L, are often utilised for small-scale production. Due to the unexpected spike in COVID-19 cases, the COVID-19 pandemic has seen an increase in demand. Due to various companies increasing their facilities to conduct research and development for COVID-19 vaccines, small-scale bioreactor sales dramatically rose in 2020 and 2021. Additionally, it is anticipated that during the forecast period, product sales will expand as a result of global immunisation efforts and increased demand.
Market Segmentation
The Global Small-scale Bioreactors Market is segmented into Product, Capacity, Distribution Channel and Growing System. By Product such as Reusable Bioreactors, Single-use Bioreactors. By Capacity such as 5 ML -100 ML, 100 ML-250 ML, 250 ML -500 ML, 500 ML-1 L, 1L-3L, 3L-5L. By End-use such as Pharmaceutical & Biopharmaceutical Companies, CROs & CMOs, Academic & Research Institutes.
Regional Analysis
Global Small-scale Bioreactors Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Small-scale Bioreactors market in North America is expected to grow at the fastest CAGR. Growing chronic illness rates and greater demand for novel biologic drugs, as well as for cutting-edge machinery like small-scale bioreactors, will spur higher investment in biopharmaceutical research, which will fuel industry expansion. For instance, in January 2022, $4 million in private finance was secured by Erbi Biosystems, a company that creates cutting-edge, portable, autonomous, and high-performance cell culture systems. The business intends to use the money from this most recent round of funding to expand operations in order to keep up with the growing demand for its Breez perfusion bioreactor and to create changes that will enhance cell therapy applications.
Due to its proximity to some of the world's most rapidly growing biotechnology economies and sectors, Asia Pacific is anticipated to see the highest CAGR during the forecast period. Some of the major firms are also growing their operations in developing nations like India to support the region's expanding biotech and pharmaceutical sectors.
Key Players
Various key players are listed in this report such as Sartorius AG, Thermo Fisher Scientific Inc, Merck KGaA, Danaher Corporation, Lonza Group, Eppendorf AG , Miltenyi Biotec, Getinge AB, Infors AG
Market Taxonomy
By Product
• Reusable Bioreactors
o Stainless Steel Bioreactors
o Glass Bioreactors
• Single-use Bioreactors
By Capacity
• 5 ML -100 ML
• 100 ML-250 ML
• 250 ML -500 ML
• 500 ML-1 L
• 1L-3L
• 3L-5L
By End-use
• Pharmaceutical & Biopharmaceutical Companies
• CROs & CMOs
• Academic & Research Institutes
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Small-scale Bioreactors Market?
• What will be the growth rate from 2023 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
Global Small-scale Bioreactors Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Small-scale Bioreactors Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Small-scale Bioreactors Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Global Small-scale Bioreactors Market Share Analysis, By Product
5.3 Global Small-scale Bioreactors Market Size and Forecast, By Product
5.3.1 Reusable Bioreactors
5.3.1.1 Stainless Steel Bioreactors
5.3.1.2 Glass Bioreactors
5.3.3 Single-use Bioreactors
6 Global Small-scale Bioreactors Market, By Capacity
6.1 Y-o-Y Growth Comparison, By Capacity
6.2 Global Small-scale Bioreactors Market Share Analysis, By Capacity
6.3 Global Small-scale Bioreactors Market Size and Forecast, By Capacity
6.3.1 5 ML -100 ML
6.3.2 100 ML-250 ML
6.3.3 250 ML -500 ML
6.3.4 500 ML-1 L
6.3.5 1L-3L
6.3.6 3L-5L
7 Global Small-scale Bioreactors Market, By End-use
7.1 Y-o-Y Growth Comparison, By End-use
7.2 Global Small-scale Bioreactors Market Share Analysis, By End-use
7.3 Global Small-scale Bioreactors Market Size and Forecast, By End-use
7.3.1 Pharmaceutical & Biopharmaceutical Companies
7.3.2 CROs & CMOs
7.3.3 Academic & Research Institutes
8 Global Small-scale Bioreactors Market, By Region
8.1 Global Small-scale Bioreactors Market Share Analysis, By Region
8.2 Global Small-scale Bioreactors Market Share Analysis, By Region
8.3 Global Small-scale Bioreactors Market Size and Forecast, By Region
9 North America Small-scale Bioreactors Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Small-scale Bioreactors Market Share Analysis, By Product
9.3 North America Small-scale Bioreactors Market Size and Forecast, By Capacity
9.4 North America Small-scale Bioreactors Market Size and Forecast, By End-use
9.6 North America Small-scale Bioreactors Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Small-scale Bioreactors Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Small-scale Bioreactors Market Share Analysis, By Product
10.3 Europe Small-scale Bioreactors Market Size and Forecast, By Capacity
10.4 Europe Small-scale Bioreactors Market Size and Forecast, By End-use
10.6 Europe Small-scale Bioreactors Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Small-scale Bioreactors Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Small-scale Bioreactors Market Share Analysis, By Product
11.3 Asia Pacific Small-scale Bioreactors Market Size and Forecast, By Capacity
11.4 Asia Pacific Small-scale Bioreactors Market Size and Forecast, By End-use
11.6 Asia Pacific Small-scale Bioreactors Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Small-scale Bioreactors Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Small-scale Bioreactors Market Share Analysis, By Product
12.3 Latin America Small-scale Bioreactors Market Size and Forecast, By Capacity
12.4 Latin America Small-scale Bioreactors Market Size and Forecast, By End-use
12.6 Latin America Small-scale Bioreactors Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Small-scale Bioreactors Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Small-scale Bioreactors Market Share Analysis, By Product
13.3 Middle East Small-scale Bioreactors Market Size and Forecast, By Capacity
13.4 Middle East Small-scale Bioreactors Market Size and Forecast, By End-use
13.6 Middle East Small-scale Bioreactors Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Sartorius AG
15.1.1 Overview
15.1.2 Products
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Thermo Fisher Scientific Inc.
15.2.1 Overview
15.2.2 Products
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Merck KGaA.
15.3.1 Overview
15.3.2 Products
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Danaher Corporation
15.4.1 Overview
15.4.2 Products
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Lonza Group
15.5.1 Overview
15.5.2 Products
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Eppendorf AG
15.6.1 Overview
15.6.2 Products
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Miltenyi Biotec
15.7.1 Overview
15.7.2 Products
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Getinge AB
15.8.1 Overview
15.8.2 Products
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Infors AG
15.9.1 Overview
15.9.2 Products
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
